Immunomic Therapeutics launches The Cancer Discovery Incubator Award.
The award will enable and accelerate beginning ventures with the capacity for measurable change in oncology health. The goal is to empower the beneficiary to conduct proof-of-concept experiments and ultimately, attract funding, partnerships, and fuel growth.
Bill Hearl was a panelist during The Washington Post's Chasing Cancer Summit. The event focused on modern healthcare cost drivers and solutions. Dr. Hearl shared his thoughts on value in health care and how companies are balancing the costs of developing and delivering innovative technologies with the need for affordable care in the treatment of cancer. Take a look at a video of the panel.
ITI wins "Life Science Company of the Year"
Immunomic Therapeutics, Inc. is the proud recipient of Tech Council of MD's "Life Science Company of the Year". Celebrated at the Industry Awards, it is the only awards ceremony that honors the best in Maryland’s life science and technology community. This celebration is one of Maryland’s largest and most prestigious award ceremonies and recognizes executives, businesses, and innovative technology developed in Maryland and the surrounding regions.
Dr. Duane Mitchell, currently leading research studies at the University of Florida with his mRNA transfected DC vaccine
that codes for pp65 and LAMP for people that suffer from Glioblastoma, received Top 10 Clinical Research Achievement Awards recognition for their ATTAC clinical trial.
ITI is looking forward to the ATTAC II trial results, which include testing full-length LAMP!
March 27 | New York, NYAnnual Neuroscience BioPartnering & Investment Forum
April 1-5 | Washington, DCAmerican Association for Cancer Research Annual Meeting
April 11 | New York, NYCancer Advance Boston
April 10-12 | Washington, DCWorld Vaccine Congress 2017
April 19-20 | Rockville, MDBioHealth Capital Region
April 27-28, 2017 | Bethesda, MDBioTech17
June 2-6, 2017 | Chicago, ILASCO Annual Meeting
We Work For Health
"We Work for Health" partnering with ITI
We Work For Health is a grassroots initiative that shows how biopharmaceutical research and medical innovation work together to create a strong, vibrant economy and a healthier America. We unite biopharmaceutical companies with business and community partners to raise awareness about the vital role we all play in delivering life-saving and life-enhancing advancements in medicine, while educating elected leaders on the impact that public policies have on our ability to continue to innovate.